Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
AJ
Amela Jusic
Translational Research Leader
Quant Biomarkers AG
Publications
8
Funding
0
Patents
0
Targeting noncoding RNAs to treat atherosclerosis
British Journal of Pharmacology
•
2025
Guidelines for mitochondrial RNA analysis
Mol Ther Nucleic Acids
•
2024
A Machine Learning Model Based on microRNAs for the Diagnosis of Essential Hypertension
Noncoding RNA
•
2023
Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems
Cardiovascular Diabetology
•
2023
Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129
Cardiovascular Research
•
2021
Correlations between Overexpression of SOX2OT Long Non-coding RNA and Susceptibility to Breast Cancer
Comb Chem High Throughput Screen .
•
2020
A Comparative Study of HOTAIR Expression in Breast Cancer Patient Tissues and Cell Lines
Cell Journal
•
2020
Approaching Sex Differences in Cardiovascular Non-Coding RNA Research
Int J Mol Sci
•
2020
AJ
Amela Jusic
Translational Research Leader
Quant Biomarkers AG
Work experience
Quant Biomarkers AG
Translational Research Leader
Top industry applications
Cardiovascular health
Medical diagnostics
Open to opportunities in
Aging
Biomolecular Processes
Biotechnology
Cardiovascular
Data Science
Machine Learning
Last updated Mar 2025
Report Error
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Subscribe
Company
About
Blog
Careers
Halo Awards
Support
FAQs
Help center
Feature requests
Contact support
Sponsors
Customer stories
Privacy Policy
Terms of Service
© 2026 Halo Cures, Inc.